🚨 NEW GLP-1 Agonist: The Triple Threat That’s Changing Medicine!Meet Retatrutide—a groundbreaking triple-agonist targeting GIP, GLP-1, and glucagon.







🚨 NEW GLP-1 Agonist: The Triple Threat That’s Changing Medicine! [juan rivera keto gummies]

🚨 NEW GLP-1 Agonist: The Triple Threat That’s Changing Medicine! [juan rivera keto gummies]

| 1h 28m 28s | Video has closed captioning.

🚨 NEW GLP-1 Agonist: The Triple Threat That’s Changing Medicine!Meet Retatrutide—a groundbreaking triple-agonist targeting GIP, GLP-1, and glucagon. 🌟 Early trials show over 24% weight loss and major blood sugar improvements. This could be the future of obesity and diabetes care! Phase 3 results are expected in 2026—stay tuned! 🚀 #ObesityCare #Diabetes #GLP1 #MetabolicHealth #Longevity

Aired: May 28, 2025

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now